Erez Israeli, CEO of Dr Reddy’s Laboratories highlights the moves he is undertaking to position his company as a market leader in India. He discusses the acquisition of a nicotine replacement therapy business, a joint venture with Nestlé India, and introducing new drugs aimed at improving standards of care as part of his growth strategy.